XTLB today

$1.63-$0.08 (-4.68%)close Nov 11, 2026

Trend

DailyUptrend (confirmed)

4 hourLeaning Bearish

1 hourStrong Bearish

15 minExpanding

5 minStrong Bearish

Daily trend turns down below $1.02

Key levels

Resistance$2.42

Resistance$2.02

Support$1.60

About XTL Biopharmaceuticals

XTL Biopharmaceuticals is an Israeli biopharmaceutical company that develops drug candidates. Its operations include Psyga Bio, which works on psychedelic-based therapies, and The Social Proxy. The company is based in Israel and its shares trade in the United States and Israel.

Based on the company's 20-F filed Jun 30, 2026.

Nasdaq · Healthcare

XTL BIOPHARMACEUTICALS LTD (XTLB)

$1.63-0.08 (-4.68%)

HOLDGrade: CRisk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High1.68

Low1.60

Open1.64

Volume5K

Avg Vol7K

VWAP1.61

30d High2.25

30d Low1.55

30d Chg-27.56%

See full chart with real-time data

What Is the Price Target for XTLB?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $1.66Upside: +0.0%Confidence: 20%Method: No Coverage

Is XTLB a Buy or Sell Right Now?

Investability Score

HOLD12-18 months

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for XTLB.

Start Free Trial →

Is XTLB Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

Moat Score

NONE

1/9

Piotroski Score

-26.4

Altman Z-Score

What Is Smart Money Doing with XTLB?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

XTLB Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

-136.5%

Revenue Trend

UNKNOWN

Dark Pool Trades for XTLB

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for XTLB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
20:18:25	$1.78	1,665	$$3K	BUY
19:20:57	$1.71	1,111	$$2K	SELL
15:47:03	$1.76	1,300	$$2K	SELL
15:46:46	$1.88	1,200	$$2K	SELL
17:31:38	$1.63	1,000	$$2K	BUY

5 dark pool trades shown · $$11K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for XTL BIOPHARMACEUTICALS LTD (XTLB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

XTLB — frequently asked questions

What is XTLB stock price today?

XTL BIOPHARMACEUTICALS LTD (XTLB) is at $1.63, down 4.68% (-$0.08) at the Nov 11, 2026 close.

Did XTLB beat earnings?

XTLB last reported on Jun 30, 2024: EPS -$0.00.

Does XTLB pay a dividend?

XTLB does not currently pay a dividend.

How much debt does XTLB have?

XTL BIOPHARMACEUTICALS LTD reported $0M of debt and $0M of cash (Dec 31, 2024).

What are XTLB support and resistance levels?

Support: $1.60. Resistance: $2.02, $2.42, $2.70.

What are insiders doing with XTLB?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.